Hsu FM - Search Results

1

Long-Term Outcomes After Cyberknife Radiosurgery for Nonfunctioning Pituitary Adenomas.

Wei N, Gunawan K, Tsai CL, Yang SH, Hsu FM, Lai DM, Xiao F. Wei N, et al. Among authors: hsu fm. Neurosurgery. 2024 Sep 12. doi: 10.1227/neu.0000000000003174. Online ahead of print. Neurosurgery. 2024. PMID: 39264192

2

Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes.

Hsieh CJ, Wu CY, Lin YH, Huang YC, Yang WC, Chen TW, Ma WL, Lin WH, Hsu FM, Xiao F, Yang SH, Lai DM, Chen CM, Chao SY, Tsuang FY. Hsieh CJ, et al. Among authors: hsu fm. Neurospine. 2023 Dec;20(4):1431-1442. doi: 10.14245/ns.2346726.363. Epub 2023 Dec 31. Neurospine. 2023. PMID: 38171309 Free PMC article.

3

How to Improve Therapeutic Ratio in Radiotherapy of HCC.

Tsai CL, Hsu FM, Cheng JC. Tsai CL, et al. Among authors: hsu fm. Liver Cancer. 2016 Jul;5(3):210-20. doi: 10.1159/000367767. Epub 2016 May 10. Liver Cancer. 2016. PMID: 27493896 Free PMC article. Review.

4

Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.

Chen YL, Huang AP, Wang CC, Chen HY, Chen YF, Xiao F, Lu SL, Cheng JC, Hsu FM. Chen YL, et al. Among authors: hsu fm. J Neurooncol. 2021 Jul;153(3):455-465. doi: 10.1007/s11060-021-03782-y. Epub 2021 Jun 7. J Neurooncol. 2021. PMID: 34100178

5

Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery.

Yang WC, Xiao F, Shih JY, Ho CC, Chen YF, Tseng HM, Chen KY, Liao WY, Yu CJ, Yang JC, Kuo SH, Cheng JC, Yang PC, Hsu FM. Yang WC, et al. Among authors: hsu fm. Radiother Oncol. 2018 Feb;126(2):368-374. doi: 10.1016/j.radonc.2017.10.010. Epub 2017 Oct 27. Radiother Oncol. 2018. PMID: 29111173

6

Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma.

Liu YF, Chiang Y, Hsu FM, Tsai CL, Cheng JC. Liu YF, et al. Among authors: hsu fm. Front Oncol. 2022 Sep 15;12:1009089. doi: 10.3389/fonc.2022.1009089. eCollection 2022. Front Oncol. 2022. PMID: 36185276 Free PMC article.

7

Biomarker studies on radiotherapy to hepatocellular carcinoma.

Tsai CL, Koong AC, Hsu FM, Graber M, Chen IS, Cheng JC. Tsai CL, et al. Among authors: hsu fm. Oncology. 2013;84 Suppl 1:64-8. doi: 10.1159/000345892. Epub 2013 Feb 20. Oncology. 2013. PMID: 23428861 Review.

8

Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study.

Tsai YC, Tsai CL, Hsu FM, Jian-Kuen W, Chien-Jang W, Cheng JC. Tsai YC, et al. Among authors: hsu fm. Med Dosim. 2013 Winter;38(4):366-71. doi: 10.1016/j.meddos.2013.04.003. Epub 2013 Jun 14. Med Dosim. 2013. PMID: 23769922 Clinical Trial.

9

High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.

Cheng JC, Graber MS, Hsu FM, Tsai CL, Castaneda L, Lee JM, Chang DT, Koong AC. Cheng JC, et al. Among authors: hsu fm. Ann Surg Oncol. 2014 Jul;21(7):2361-8. doi: 10.1245/s10434-014-3611-z. Epub 2014 Mar 13. Ann Surg Oncol. 2014. PMID: 24623035

10

Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.

Tsai CL, Hsu FM, Tzen KY, Liu WL, Cheng AL, Cheng JC. Tsai CL, et al. Among authors: hsu fm. J Gastroenterol Hepatol. 2015 Aug;30(8):1317-24. doi: 10.1111/jgh.12931. J Gastroenterol Hepatol. 2015. PMID: 25682950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters